نتائج البحث - "Morabito A."

1

Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial

المساهمون: Cascinu, S., Berardi, R., Bianco, R., Bilancia, D., Zaniboni, A., Ferrari, D., Mosconi, S., Spallanzani, A., Cavanna, L., Leo, S., Negri, F., Beretta, G. D., Sobrero, A., Banzi, M., Morabito, A., Bittoni, A., Marciano, R., Ferrara, D., Noventa, S., Piccirillo, M. C., Labianca, R., Mosconi, C., Casadei Gardini, A., Gallo, C., Perrone, F., Cascinu, Stefano, Berardi, Rossana, Bianco, Roberto, Bilancia, Domenico, Zaniboni, Alberto, Ferrari, Dari, Mosconi, Stefania, Spallanzani, Andrea, Cavanna, Luigi, Leo, Silvana, Negri, Francesca, Beretta, Giordano D, Sobrero, Alberto, Banzi, Maria, Morabito, Alberto, Bittoni, Alessandro, Marciano, Roberta, Ferrara, Domenica, Noventa, Silvia, Piccirillo, Maria C, Labianca, Roberto, Mosconi, Cristina, Casadei Gardini, Andrea, Gallo, Ciro, Perrone, Francesco

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, medicine.medical_treatment, Gastroenterology, Deoxycytidine, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Medicine, Advanced pancreatic cancer, Nab-paclitaxel, Unresectable Pancreatic Cancer, Pancreatic Neoplasm, Combination chemotherapy, Middle Aged, Prognosis, Survival Rate, Oncology, 030220 oncology & carcinogenesis, Female, medicine.drug, Human, Adult, medicine.medical_specialty, Paclitaxel, Prognosi, Locally advanced, Adenocarcinoma, Follow-Up Studie, 03 medical and health sciences, Phase II randomized trial, Internal medicine, Albumins, Humans, Aged, Chemotherapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Albumin, medicine.disease, Gemcitabine, Pancreatic Neoplasms, 030104 developmental biology, Paclitaxel and gemcitabine, business, Progressive disease, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c376e62a6b974a269dc1a734997b60dTest
http://hdl.handle.net/11591/461643Test

2

Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy

المساهمون: Pulmonary Medicine

المصدر: Thoracic Cancer, 13(3), 483-488. Blackwell Publishing
Thoracic Cancer
Thoracic Cancer, Vol 13, Iss 3, Pp 483-488 (2022)

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2a507fddad4ba991a1e8a4c953a4a0dTest
https://hdl.handle.net/11567/1073050Test

3

Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients

المساهمون: Caracciolo, M., Correale, P., Mangano, C., Foti, G., Falcone, C., Macheda, S., Cuzzola, M., Conte, M., Falzea, A. C., Iuliano, E., Morabito, A., Caraglia, M., Polimeni, N., Ferrarelli, A., Labate, D., Tescione, M., Di Renzo, L., Chiricolo, G., Romano, L., De Lorenzo, A.

المصدر: Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology

مصطلحات موضوعية: Male, 0301 basic medicine, Adenosine, Azithromycin, Settore MED/49, Gastroenterology, Lopinavir, 0302 clinical medicine, Enzyme Inhibitor, Immunology and Allergy, Medicine, 030212 general & internal medicine, Enzyme Inhibitors, Tomography, Original Research, Mortality rate, Middle Aged, Prognosis, Pathophysiology, Anti-Bacterial Agents, X-Ray Computed, Hospitalization, Female, medicine.symptom, Case-Control Studie, Cytokine Release Syndrome, Cytochrome P-450 CYP3A Inhibitor, Human, Hydroxychloroquine, medicine.drug, lcsh:Immunologic diseases. Allergy, Adult, medicine.medical_specialty, Prognosi, Immunology, Inflammation, COVID-19, SARS-CoV-2, Length of stay, Aged, Case-Control Studies, Cytochrome P-450 CYP3A Inhibitors, Heparin, Humans, Tomography, X-Ray Computed, 03 medical and health sciences, Pharmacotherapy, Immune system, Internal medicine, Anti-Bacterial Agent, business.industry, Case-control study, medicine.disease, COVID-19 Drug Treatment, 030104 developmental biology, lcsh:RC581-607, business, Cytokine storm

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0295fa627a2422b810291ad5dcf68687Test
https://doi.org/10.3389/fimmu.2021.613070Test

4

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

المؤلفون: Andrea Bacigalupo, Pierre Fenaux, Alberto Termanini, Marianna Rossi, Lucio Morabito, Niccolo Bolli, Massimo Bernardi, Victor Savevski, Manja Meggendorfer, Daniel Remondini, Tommaso Matteuzzi, Torsten Haferlach, Luciano Milanesi, Matteo G. Della Porta, Ettore Mosca, Gastone Castellani, Valeria Santini, Alessandro Rambaldi, Giulia Maggioni, Guillermo Sanz, Claudia Sala, Wolfgang Kern, Marta Ubezio, Matteo Zampini, Emanuele Angelucci, Armando Santoro, Laura Palomo, Noemi Di Nanni, Lorenza Borin, Erica Travaglino, Alessia Campagna, Maria Teresa Voso, Francesc Solé, Francesca Bonifazi, Shahram Kordasti, Uwe Platzbecker, Matteo Bersanelli, Matteo Gnocchi, Esther Oliva, Marta Riva, Benedetto Bruno, Fabio Ciceri, Francesco Passamonti, Claudia Saitta, Enrico Giampieri, Chiara Chiereghin

المساهمون: Bersanelli, Matteo, Travaglino, Erica, Meggendorfer, Manja, Matteuzzi, Tommaso, Sala, Claudia, Mosca, Ettore, Chiereghin, Chiara, Di Nanni, Noemi, Gnocchi, Matteo, Zampini, Matteo, Rossi, Marianna, Maggioni, Giulia, Termanini, Alberto, Angelucci, Emanuele, Bernardi, Massimo, Borin, Lorenza, Bruno, Benedetto, Bonifazi, Francesca, Santini, Valeria, Bacigalupo, Andrea, Voso, Maria Teresa, Oliva, Esther, Riva, Marta, Ubezio, Marta, Morabito, Lucio, Campagna, Alessia, Saitta, Claudia, Savevski, Victor, Giampieri, Enrico, Remondini, Daniel, Passamonti, Francesco, Ciceri, Fabio, Bolli, Niccolò, Rambaldi, Alessandro, Kern, Wolfgang, Kordasti, Shahram, Sole, Francesc, Palomo, Laura, Sanz, Guillermo, Santoro, Armando, Platzbecker, Uwe, Fenaux, Pierre, Milanesi, Luciano, Haferlach, Torsten, Castellani, Gastone, Della Porta, Matteo G

المصدر: Journal of Clinical Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Journal of clinical oncology (2021): 1223–1233. doi:10.1200/JCO.20.01659
info:cnr-pdr/source/autori:Matteo Bersanelli, PhD1,2; Erica Travaglino, BSc3; Manja Meggendorfer, PhD4; Tommaso Matteuzzi, PhD1,2; Claudia Sala, PhD1,2; Ettore Mosca, PhD5; Chiara Chiereghin, PhD3; Noemi Di Nanni, PhD5; Matteo Gnocchi, MSc5; Matteo Zampini, PhD3; Marianna Rossi, MD3; Giulia Maggioni, MD3,6; Alberto Termanini, PhD3; Emanuele Angelucci, MD7; Massimo Bernardi, MD8; Lorenza Borin, MD9; Benedetto Bruno, MD10,11; Francesca Bonifazi, MD12; Valeria Santini, MD13; Andrea Bacigalupo, MD14; Maria Teresa Voso, MD15; Esther Oliva, MD16; Marta Riva, MD17; Marta Ubezio, MD3; Lucio Morabito, MD3; Alessia Campagna, MD3; Claudia Saitta, MSc18; Victor Savevski, MEng3; Enrico Giampieri, PhD2,19; Daniel Remondini, PhD1,2; Francesco Passamonti, MD20; Fabio Ciceri, MD8; Niccolò Bolli, MD21,22; Alessandro Rambaldi, MD23; Wolfgang Kern, MD4; Shahram Kordasti, MD24,25; Francesc Sole, PhD26; Laura Palomo, PhD26; Guillermo Sanz, MD27,28; Armando Santoro, MD3,6; Uwe Platzbecker, MD29; Pierre Fenaux, MD30; Luciano Milanesi, PhD5; Torsten Haferlach, MD4; Gastone Castellani, PhD2,19; and Matteo G. Della Porta, MD3,6/titolo:Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes/doi:10.1200%2FJCO.20.01659/rivista:Journal of clinical oncology/anno:2021/pagina_da:1223/pagina_a:1233/intervallo_pagine:1223–1233/volume
JOURNAL OF CLINICAL ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

مصطلحات موضوعية: Male, Cancer Research, SCORING SYSTEM, MODELS, disease classification, MEDLINE, ACUTE MYELOID-LEUKEMIA, Computational biology, 03 medical and health sciences, 0302 clinical medicine, Text mining, hemic and lymphatic diseases, MDS, medicine, CRITERIA, Humans, NGS, somatic mutations, myelodysplastic syndromes, prognosis, 030304 developmental biology, Retrospective Studies, 0303 health sciences, GENETIC LESIONS, business.industry, Myelodysplastic syndromes, Disease classification, Retrospective cohort study, SOMATIC MUTATIONS, Genomics, MDS, Artificial Intekkìlligence, machine learning, Settore MED/15, medicine.disease, Prognosis, 3. Good health, Oncology, 030220 oncology & carcinogenesis, Myelodysplastic Syndromes, Female, prognostication, business

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44aaf502fa9b84c6f3bcd94939d29f3dTest
https://pubmed.ncbi.nlm.nih.gov/33539200Test

5

المؤلفون: Raffaele Giusti, Giorgia Guaitoli, Mario Occhipinti, Diego Cortinovis, Ornella Cantale, Luca Cantini, Cinzia Baldessari, Alessio Cortellini, Francesco Grossi, Linda Pettoruti, Vincenzo Sforza, Giovanni Mansueto, Francesco Passiglia, Francesca Mazzoni, Lorenza Landi, Alain Gelibter, Melissa Bersanelli, Daniele Santini, Paolo Marchetti, Alessandro Morabito, Alessandro Leonetti, Marianna Tudini, Serena Ricciardi, Fabrizio Citarella, Ettore D'Argento, Francesca Rastelli, Matteo Santoni, Vincenzo Di Noia, Giampiero Porzio, Robert A. Belderbos, Claudia Proto, Simona Scodes, Marianna Macerelli, Marco Filetti, Joachim G.J.V. Aerts, Diego Signorelli, Luigi Della Gravara, Carlo Genova, Danilo Rocco, Lorenzo Antonuzzo, Alessandro Tuzi, Cristina Cecchi, Luca Sala, Corrado Ficorella, Marco De Filippis, Giuseppe Luigi Banna, Alessandro Inno, Mariangela Torniai, Pamela Pizzutilo, Emilio Bria, Maria Giovanna Dal Bello, Domenico Galetta, Federico Cappuzzo, Federica Bertolini, Rossana Berardi, Maria Rita Migliorino, Miriam Grazia Ferrara, Clelia Donisi, Rita Chiari, Alessandro De Toma, Olga Nigro, Michele Ghidini, Annamaria Catino, Alfredo Addeo, Federica Zoratto, Alessandro Follador, Pietro Di Marino, Alex Friedlaender, Marco Russano, Biagio Ricciuti, Katia Cannita

المساهمون: Pulmonary Medicine

المصدر: Clinical Lung Cancer, 21(6), 498-508.e2. Elsevier

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Adult, Male, PD-L1, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Drug-Related Side Effects and Adverse Reactions, First line, irAEs, NSCLC, Pembrolizumab, Immune checkpoint inhibitors, Antibodies, Monoclonal, Humanized, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Immune system, Antineoplastic Agents, Immunological, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Adverse effect, Lung cancer, Aged, Retrospective Studies, Aged, 80 and over, biology, business.industry, Middle Aged, medicine.disease, Prognosis, Survival Rate, 030104 developmental biology, 030220 oncology & carcinogenesis, Cohort, biology.protein, Carcinoma, Squamous Cell, Pd l1 expression, Female, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::531621b29708da404fb5e5130661d486Test
https://pure.eur.nl/en/publications/1e14e673-632c-43f9-9fef-78675b6ec8e3Test

6

Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study

المساهمون: Gentile M., Morabito F., Del Poeta G., Mauro F.R., Reda G., Sportoletti P., Laurenti L., Coscia M., Herishanu Y., Recchia A.G., Varettoni M., Murru R., Chiarenza A., Condoluci A., Moia R., Pietrasanta D., Loseto G., Consoli U., Scortechini I., Rossi F.M., Zucchetto A., Fraticelli V., Vigna E., Botta C., Tripepi G., Arrigo G.D., Rago A., Angeletti I., Biagi A., Del Giudice I., Bomben R., Rigolin G.M., Rossi D., Di Raimondo F., Gaidano G., Polliack A., Cuneo A., Foa R., Gattei V.

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Survival risk score, Chronic lymphocytic leukemia, Treatment outcome, Antineoplastic Agents, risk score, NO, chemistry.chemical_compound, relapsed/refractory chronic lymphocytic leukemia, Antineoplastic Agents, Immunological, Piperidines, ibrutinib, Internal medicine, medicine, Humans, real-life, Molecular Targeted Therapy, Chronic, Protein Kinase Inhibitors, Framingham Risk Score, Leukemia, chronic lymphocytic leukemia, prognosis, business.industry, Adenine, B-Cell, Hematology, medicine.disease, Prognosis, Leukemia, Lymphocytic, Chronic, B-Cell, prognostic score, Lymphocytic, Survival risk score, real-life, relapsed/refractory chronic lymphocytic leukemia, ibrutinib, Settore MED/15 - MALATTIE DEL SANGUE, Immunological, Treatment Outcome, chemistry, Ibrutinib, Relapsed refractory, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed3d7c0cdcb620f1a8e81a9720ce59e2Test
http://hdl.handle.net/2318/1760439Test

7

Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study

المؤلفون: Ilaria Scortechini, Riccardo Moia, Marzia Varettoni, Francesca Romana Mauro, Sara Galimberti, Giovanni Del Poeta, Graziella D'Arrigo, Marta Coscia, Luca Laurenti, Ernesto Vigna, Davide Rossi, Annalisa Biagi, Gianluca Gaidano, Daniele Caracciolo, Riccardo Bomben, Ilaria Angeletti, Gianluigi Reda, Giovanna Cutrona, Daniela Pietrasanta, Gilberto Fronza, Ramona Cassin, Antonino Neri, Aaron Polliack, Annalisa Chiarenza, Yair Herishanu, Fortunato Morabito, Ilaria Del Giudice, Valter Gattei, Francesca Rossi, Roberta Murru, Giovanni Tripepi, Andrea Visentin, Livio Trentin, Antonio Cuneo, Angela Rago, Antonella Zucchetto, Adalgisa Condoluci, Giacomo Loseto, Ugo Consoli, Enrica Antonia Martino, Manlio Ferrarini, Massimo Gentile, Francesco Di Raimondo, Francesco Mendicino, Paolo Sportoletti, Robin Foà, Cirino Botta

المساهمون: Morabito F., Tripepi G., Del Poeta G., Mauro F.R., Reda G., Sportoletti P., Laurenti L., Coscia M., Herishanu Y., Varettoni M., Murru R., Chiarenza A., Visentin A., Condoluci A., Moia R., Pietrasanta D., Loseto G., Consoli U., Scortechini I., Rossi F.M., Zucchetto A., Vigna E., Martino E.A., Mendicino F., Botta C., Caracciolo D., Cassin R., D'Arrigo G., Galimberti S., Rago A., Angeletti I., Biagi A., Del Giudice I., Bomben R., Neri A., Fronza G., Cutrona G., Rossi D., Di Raimondo F., Cuneo A., Gaidano G., Polliack A., Trentin L., Foa R., Ferrarini M., Gattei V., Gentile M.

مصطلحات موضوعية: Oncology, Male, chronic B cell leukemia, chronic lymphocytic leukemia, ibrutinib, 4-factor score, prognosis, Datasets as Topic, Severity of Illness Index, chemistry.chemical_compound, Piperidines, Retrospective analysis, Multicenter Studies as Topic, Chronic, Leukemia, Hematology, Middle Aged, Prognosis, Lymphocytic, Progression-Free Survival, Ibrutinib, Female, medicine.medical_specialty, real-word study, Factor score, Antineoplastic Agents, Adenine, Aged, Follow-Up Studies, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Proportional Hazards Models, Protein Kinase Inhibitors, Reproducibility of Results, Retrospective Studies, Risk Assessment, Survival Analysis, NO, Internal medicine, Severity of illness, medicine, Progression-free survival, Survival analysis, business.industry, Proportional hazards model, B-Cell, Retrospective cohort study, Settore MED/15 - MALATTIE DEL SANGUE, chemistry, business, chronic lymphocytic leukaemia

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad82db1eebab16c1153d0fa0408ce813Test
http://hdl.handle.net/2318/1801336Test

8

LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cells

المؤلفون: Monica Colombo, Martina Cardillo, Franco Fais, Adalberto Ibatici, Antonino Neri, Roberto Gherzi, Fortunato Morabito, Tiziana Vaisitti, Sonia Fabris, Giovanna Cutrona, Silvia Bruno, Lorenzo Brondolo, Daniele Reverberi, Martina Rossi, Paola Briata, Massimo Gentile, Emanuele Angelucci, Serena Matis, Rosanna Massara

المصدر: Hematological oncology. 40(1)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5ac9f4b88612b3db882eaeb13e77fceTest
https://pubmed.ncbi.nlm.nih.gov/34679195Test

9

Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study

المؤلفون: Ettore D'Argento, Marco Russano, Giada Targato, Giovanni Mansueto, Cinzia Baldessari, Katia Cannita, Alessandro Russo, A. Guida, Diego Cortinovis, Lorenza Landi, Miriam Grazia Ferrara, Giampiero Porzio, Francesca Rastelli, Michele De Tursi, Luca Cantini, Salvatore Natalizio, Federica Zoratto, Alex Friedlaender, Vincenzo Adamo, Massimo Di Maio, Francesca Mazzoni, Sergio Bracarda, Diego Signorelli, Lorenzo Antonuzzo, Marco De Filippis, Alfredo Addeo, David J. Pinato, Corrado Ficorella, Rita Chiari, Sebastiano Buti, Alessandro Morabito, Alessandro De Toma, Maria Rita Migliorino, Carlo Genova, Danilo Rocco, Olga Nigro, Fabrizio Citarella, Raffaele Giusti, Joachim G.J.V. Aerts, Rossana Berardi, Francesco Grossi, Gian Paolo Spinelli, Serena Ricciardi, Gabriele Minuti, Marco Filetti, Giulio Metro, Marcello Tiseo, Carnio Simona, Alessio Cortellini, Alain Gelibter, Stefania Gori, Giuseppe Luigi Banna

المساهمون: Pulmonary Medicine

المصدر: European Journal of Cancer, 148, 24-35. Elsevier Ltd.

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Lung Neoplasms, medicine.medical_treatment, Pembrolizumab, Post-progression, B7-H1 Antigen, Antineoplastic Agents, Immunological, 0302 clinical medicine, Non-small cell lung cancer, Carcinoma, Non-Small-Cell Lung, Monoclonal, 80 and over, Non-Small-Cell Lung, Humanized, Aged, 80 and over, Liver Neoplasms, Bone metastasis, Middle Aged, Prognosis, Survival Rate, Radiation therapy, Immunological, 030220 oncology & carcinogenesis, Cohort, Female, Immunotherapy, Performance status, Cohort study, Adult, PD-L1, medicine.medical_specialty, Antineoplastic Agents, Bone Neoplasms, Antibodies, Monoclonal, Humanized, Antibodies, Radiotherapy, 03 medical and health sciences, Drug withdrawal, SDG 3 - Good Health and Well-being, Internal medicine, medicine, Humans, Aged, Retrospective Studies, Chemotherapy, business.industry, Carcinoma, medicine.disease, 030104 developmental biology, Case-Control Studies, Follow-Up Studies, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7314dcc156fff7a98a3cb14a0047ab96Test
https://pure.eur.nl/en/publications/350c0c97-d2a7-4035-86c5-6de83e0c6264Test

10

A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia

المساهمون: Cohen, Ja, Rossi, Fm, Zucchetto, A, Bomben, R, Terzi-di-Bergamo, L, Rabe, Kg, Degan, M, Steffan, A, Polesel, J, Santinelli, E, Innocenti, I, Cutrona, G, D'Arena, G, Pozzato, G, Zaja, F, Chiarenza, A, Rossi, D, Di Raimondo, F, Laurenti, L, Gentile, M, Morabito, F, Neri, A, Ferrarini, M, Fegan, Cd, Pepper, Cj, Del Poeta, G, Parikh, Sa, Kay, Ne, Gattei, V.

المصدر: Haematologica

وصف الملف: application/pdf; STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0bf164e9fb4f7c1af51f7f18befe908Test
http://sro.sussex.ac.uk/id/eprint/90077/1/Ah7g7W-haematol.2019.228171.full.pdfTest

تنقيح النتائج